Products

In certain places, BD Medical also offers consulting and analytics related services. In 2024, BD announced it would acquire Edwards Lifesciences’ critical care unit for $4.2 billion. In July 2021, BD announced it would acquire surgical scaffold maker Tepha, after having acquired Velano Vascular earlier the same month. This agreement protects patents and intellectual properties of both companies ensuring the quality and integrity of Embecta Corporation’s cannulas used in their products. The transaction was completed later that year, and the company became a wholly-owned subsidiary of BD, rebranded as Bard.

Advancing the world of health™

By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. Based in Mexico City, to produce syringes, needles and clinical thermometers for the Mexican market. 1995 BD formed a subsidiary in India to manufacture insulin syringes and to market other medical and diagnostic products to the region. We welcome people with imagination and drive – people who want to grow, make a difference and help reinvent the future of healthcare.

Shape what’s next,for healthcareand for your career

2015 BD became the first to integrate IV pumps with electronic health records.\r\n 2017 The first clinical lab application of artificial intelligence and robotics to automatically report and release negative urine cultures is utilized.\r\n 2019 BD launched the first venous stent to treat iliofemoral venous occlusive disease.\r\n 2020 BD launched the first sample preparation and flow cytometry system to enable clinical laboratories to fully automate the sample-to-answer process.

• 2014 BD launched the first FDA-approved drug coated balloon for peripheral artery disease.
• BD recalled and tested the syringes in question, and revealed sterile particulates in 0.013 percent of the products.
• 1988 BD launched the first safety engineered syringe.
• 2019 BD launched the first venous stent to treat iliofemoral venous occlusive disease.\r\n
• In 2024, BD announced it would acquire Edwards Lifesciences’ critical care unit for $4.2 billion.

In October 2014, the company agreed to acquire CareFusion for a price of US$12.2 billion in cash and stock. Later Retractable would claim BD was falsely advertising its own brand of retractable needle as the “world’s sharpest needle”. Retractable would accuse BD of patent infringement after BD released a retractable needle of its own. The company was founded in 1897 in New York City by Maxwell Becton and Fairleigh S. Dickinson. We know that possibilities are endless when people feel supported and inspired.

1987 BD built a plant to manufacture diagnostic products in khelovip live Fukushima, Japan. 1999 The world’s shortest, thinnest insulin pen needle is introduced. 2007 BD AutoShield™ needle is launched.

At BD, your ideas, curiosity and purpose can makea global impact In December 2025, BD was sued by Tela Bio Inc., makers of a ovine forestomach matrix hernia mesh, who alleged that BD engaged in anticompetitive practices to push Tela out of the market for surgical meshes while raising prices for providers and patients. Food and Drug Administration and worldwide health agencies to coordinate recall activities. The approximately 2.8 million BD Q-Syte and 2.9 million BD Nexiva units containing 5 million BD Q-Syte devices that were recalled were distributed in the United States, Asia, Canada, Europe, Mexico, the Middle East, South Africa, and South America.

Our Purpose drives us to create innovative solutions that make a meaningful impact on advancing the world of health™. At BD, we believe that people are at the heart of every breakthrough, solution, and step forward.

BD Medical’s Consulting services are primarily targeted at hospitals, healthcare systems and networks of healthcare providers.citation needed Quality of care, cost efficiency, healthcare worker and patient safety and experience Medical Essentials forms the foundation of health care delivery, producing billions of devices each year that ensure safe medication administration and support accurate diagnostics. 1913 BD merged with Oscar O.R. Schwidetzky’s surgical import company, bringing his Asepto™ bulb syringe along with helping to develop the American-made ACE® bandage.